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The transcriptional repressor Blimp1 is expressed in rare luminal
progenitors and is essential for mammary gland development
Mohammed I. Ahmed*, Salah Elias*, Arne W. Mould, Elizabeth K. Bikoff and Elizabeth J. Robertson‡
ABSTRACT
Mammary glandmorphogenesis depends on a tight balance between
cell proliferation, differentiation and apoptosis, to create a defined
functional hierarchy within the epithelia. The limited availability of
stem cell/progenitor markers has made it challenging to decipher
lineage relationships. Here, we identify a rare subset of luminal
progenitors that express the zinc finger transcriptional repressor
Blimp1, and demonstrate that this subset of highly clonogenic luminal
progenitors is required for mammary gland development. Conditional
inactivation experiments using K14-Cre andWAPi-Cre deleter strains
revealed essential functions at multiple developmental stages. Thus,
Blimp1 regulates proliferation, apoptosis and alveolar cell maturation
during puberty and pregnancy. Loss of Blimp1 disrupts epithelial
architecture and lumen formation both in vivo and in three-
dimensional (3D) primary cell cultures. Collectively, these results
demonstrate that Blimp1 is required to maintain a highly proliferative
luminal subset necessary for mammary gland development and
homeostasis.
KEY WORDS: Blimp1, Prdm1, Transcriptional repressor,
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INTRODUCTION
The mammary gland, a defining feature of mammals, is a highly
specialized organ that produces and delivers milk from the mother
to the newborn. The resulting nutritional benefits and postnatal
immune protection are credited with the evolutionary success of
mammals. Its orchestrated morphogenesis during puberty,
pregnancy, lactation and involution make the mammary gland a
powerful model system for studying the genetic circuits controlling
epithelial growth and development. Mammary glands initially
become visible at around embryonic day (E) 11.5 as placode-like
structures that progressively invade the underlying mesenchyme,
the so-called mammary fat pad, to form an epithelial tree
(Hennighausen and Robinson, 2005). The epithelium is
composed of two distinct populations: the outer myoepithelial/
basal cells and the inner luminal cells. Extensive elongation and
branching of the ducts via the terminal end buds (TEBs) during
puberty generates the mature ductal network. Subsequent expansion
during pregnancy in response to steroid hormones gives rise to
highly specialized milk-producing alveoli. During the suckling-to-
weaning transition, the alveoli undergo a process of involution
leading to regression of the gland (Visvader and Stingl, 2014).
Mammary stem cells (MaSCs) within the epithelium are
responsible for its striking regenerative capacity upon successive
rounds of pregnancy (Hoshino and Gardner, 1967; Smith and
Medina, 1988). MaSCs, sharing characteristics of basal cells, lack
steroid hormone receptors (Asselin-Labat et al., 2010; Shackleton
et al., 2006; Stingl et al., 2006). The striking morphological changes
during pregnancy are triggered in response to RANKL (also known
as Tnfsf11) paracrine signalling activated by adjacent oestrogen and
progesterone-responsive (ERα+PR+; also known as Esr1 and Pgr,
respectively) luminal cells (Asselin-Labat et al., 2010; Joshi et al.,
2010). Recent studies have identified several distinct stem and
progenitor cell subpopulations (Shackleton et al., 2006; Shehata
et al., 2012; Stingl et al., 2006; Villadsen et al., 2007). The cell fate
choices made during mammary gland development have been
extensively studied, but the precise details of lineage commitment
remain controversial. Both unipotent and bipotent progenitors
giving rise to luminal and/or myoepithelial basal subpopulations
have been identified in lineage-tracing experiments (Van
Keymeulen et al., 2011; van Amerongen, et al., 2012; Prater
et al., 2014; Rios et al., 2014;Wang et al., 2015). The heterogeneous
luminal compartment is known to contain several distinct cell
subpopulations that display diverse differentiation states and
proliferative capacities (Lafkas et al., 2013; Rodilla et al., 2015;
Sale et al., 2013; Shehata et al., 2012; Sleeman et al., 2007). A
subset of ERα+ luminal cells considered to be functionally mature
rarely proliferate in adult mammary tissue (Russo et al., 1999;
Shehata et al., 2012). By contrast, ERα− luminal cells that robustly
express the Ets transcription factor Elf5 function as highly
proliferative alveolar progenitors (Oakes et al., 2008; Rios et al.,
2014; Rodilla et al., 2015; Sleeman et al., 2007). This high degree of
cellular heterogeneity, in combination with the limited availability
of stem/progenitor markers, has made it challenging to define
lineage hierarchies.
The zinc finger transcriptional repressor B-lymphocyte-induced
maturation protein 1 (Blimp1; also known as Prdm1), originally
cloned as negative regulator of β-interferon gene expression (Keller
and Maniatis, 1991) and subsequently identified as a master
regulator of plasma cell terminal differentiation (Martins and
Calame, 2008; Shapiro-Shelef et al., 2003), governs cell fate
decisions in the developing embryo and adult tissues (Bikoff et al.,
2009). In B cells and macrophages, Blimp1 represses Myc
expression to arrest cellular proliferation (Martins and Calame,
2008), whereas in activated T lymphocytes, Blimp1 targets the
cytokine IL-2 to block cell proliferation and promote effector T-cell
maturation (Martins et al., 2008). In the early embryo, Blimp1 is
required to specify the primordial germ-cell lineage (Ohinata et al.,
2005; Vincent et al., 2005), and at later developmental stages
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forelimbs and placenta (Mould et al., 2012; Robertson et al., 2007).
In the skin, Blimp1 maintains tissue homeostasis and epithelial
barrier function (Kretzschmar et al., 2014; Magnusdottir et al.,
2007). Blimp1 regulates the developmental switch responsible for
postnatal reprogramming of the intestinal epithelium (Harper et al.,
2011; Muncan et al., 2011). Recent studies demonstrate that Blimp1
functions as a gatekeeper in opposition to Irf1 to prevent premature
activation of the MHC class I pathway in the fetal enterocytes and to
maintain tolerance in the neonatal intestine in the first few weeks
after birth, during colonization of the intestinal tract by commensal
microorganisms (Mould et al., 2015). In human breast cancer cell
lines, Blimp1 functions downstream of TGFβ1, RelB and Ras
signalling to induce epithelial-mesenchymal transition (EMT)
(Romagnoli et al., 2012; Wang et al., 2009). Blimp1 contributions
during normal mammary gland development and tissue
homeostasis have yet to be investigated.
Here, we demonstrate that Blimp1 expression marks a subset of
Elf5+ERα−PR− luminal-alveolar progenitors, primed in response to
pregnancy hormones. Blimp1 function is essential for ductal
morphogenesis during puberty and lobuloalveolar maturation
during late pregnancy and lactation. Conditional inactivation
disrupts the ability of luminal cells to polarize properly, leading to
defective milk secretion. Collectively, these findings demonstrate
for the first time that Blimp1 plays an essential role in controlling
mammary gland development.
RESULTS
Developmentally regulated Blimp1 expression is restricted
to the luminal compartment
Western blot experiments have demonstrated that Blimp1
expression in mammary gland tissue is robustly activated during
pregnancy (Romagnoli et al., 2012). To characterize Blimp1+ cell
populations, we performed immunostaining experiments. At day 6
of pregnancy (P6.5) we observed Blimp1+ cells localized within
the luminal compartment of epithelial structures (Fig. 1A). The
highest numbers of Blimp1+ cells were present in the alveolar
structures during late pregnancy and lactation. During involution,
Blimp1 expression is confined to a small number of luminal cells
within the regressing epithelium (Fig. 1A). Scattered Blimp1+
cells are also detectable within the stromal population (Fig. 1A).
qRT-PCR analysis of basal (Lin−CD24lowCD49FhighKrt14+) and
luminal (Lin−CD24highCD49FlowKrt8+) (CD49F is also known as
Itga6) subpopulations isolated from 12-week-old virgin and P18.5
mammary tissue using flow cytometry (Fig. S1A,B) confirmed
that Blimp1 expression is restricted to the luminal compartment
(Fig. S1C). Next, we exploited a BAC transgenic reporter strain
expressing membrane Venus (mVenus) under control of the
Blimp1 regulatory elements (Ohinata et al., 2008). In pubertal
(5 weeks of age), and mature (10 weeks of age) virgins, a small
subset of Blimp1-Venus+ (BV+) cells were visible in the TEBs,
with fewer BV+ cells detected in the mature virgin mammary
epithelium (Fig. 1B). Immunofluorescence experiments
demonstrate that BV+ cells selectively co-expressed the luminal
marker Krt8 and not the basal marker Krt14. Increased numbers of
BV+ cells were present in alveolar structures during pregnancy
(Fig. 1B).
Blimp1 expression marks a rare subset of luminal
progenitors
By flow cytometry we identified two distinct BV+ cell
subpopulations (Fig. S1). As expected (Arulanandam et al., 2015;
Vincent et al., 2005), Blimp1 is robustly expressed in CD31+ (also
known as Pecam1) endothelial cells. BV+Lin+CD24−CD49F−
endothelial cells represent 2.8% and 2.4% of total dissociated cells
in 12-week-old virgin and P18.5 pregnant mammary glands,
respectively (Fig. S1E). Additionally, we observe a rare
population of BV+Lin−CD24highCD49Flow luminal cells
comprising 0.44% and 0.48% of total dissociated cells,
respectively (Fig. S1D,E). In situ experiments demonstrate that
these BV+ luminal cells express Elf5 but lack ERα and PR
(Fig. 2A,B), suggesting that they correspond to a previously
described subset of luminal progenitors (Shehata et al., 2012). To
examine the proliferative status of these BV+ luminal cells, we
assessed Ki67 (also known as Mki67) expression. In mature virgin
Fig. 1. Blimp1 expression is restricted
to the luminal cell compartment of
the developing mammary gland.
(A) Blimp1 immunohistochemical
staining of mammary gland tissue during
pregnancy (P6.5, P12.5 and P18.5) and
at day 1 of lactation and day 5 of
involution. During pregnancy, lactation
and involution, Blimp1+ cells are
confined to the luminal cell compartment
of alveolar structures (arrowheads).
(B) Cryosections from 5- and 10-week-
old virgins and P18.5 Blimp1-Venus (BV)
mammary glands stained for GFP
(green) and Krt8 (K8; red) or Krt14
(K14; red). Blimp1-expressing cells
(green) are Krt8+ and Krt14−.
High-magnification images of the boxed
areas are shown to the right of each
image. Scale bars: 50 μm.
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epithelium, the majority of BV+ cells are quiescent (Fig. 2C).
However, during puberty and at P6.5, representation of double-
positive BV+ Ki67+ cells is dramatically increased (Fig. 2C,D).
To investigate directly their proliferative capabilities, sorted
BV+ luminal cells recovered from 12-week-old virgin and P18.5
pregnant females were tested in three-dimensional (3D) Matrigel
cultures (Fig. 2E,F). The colony-forming efficiencies (2.6- and
3.2-fold, respectively) of the BV+ cell fraction were markedly
enriched compared with the total starting luminal cell population
(Fig. 2F). Thus, ∼40% of plated BV+ luminal cells from 12-week-
old virgins formed colonies compared with 14% of the starting
luminal cell population (Fig. 2F). Moreover ∼80% of the BV+
luminal cells from P18.5 mammary glands formed colonies
compared with ∼25% of the total cell population. By contrast,
however, only ∼6% and ∼9% of BV− luminal cells isolated at
P18.5 and 12 weeks of age, respectively, formed colonies,
indicating that this cell population has much-reduced clonogenic
potential (Fig. 2F). Thus, BV+ luminal cells potentially represent a
highly proliferative progenitor cell population that markedly
expands during pregnancy.
Blimp1 expression becomes dramatically upregulated in
response to steroid hormones
Next, we treated ovariectomized wild-type females or females
carrying the Prdm1Cre.IRES.nLacZ reporter allele (Mould et al., 2012)
with a cocktail of 17β-oestradiol (E2) and progesterone (Pg). As
expected, E2+Pg hormone injections resulted in mammary gland
expansion and the formation of lobuloalveolar structures (Fig. 3B).
X-gal staining and immunostaining reveal markedly increased
Blimp1 expression in the ducts and nascent alveolar buds
(Fig. 3B,C). Similarly, RANKL treatment in 3D cultures of
primary mammary epithelial cells (MECs) from pregnant
Prdm1Cre.IRES.nLacZ reporter mice results in increased numbers of
Blimp1-lacZ+ cells (Fig. 3D,E). Thus, Blimp1 expression marks
progenitors that proliferate in response to steroid hormones to
generate the alveolar structures.
Blimp1 functional requirements during ductal
morphogenesis, lumen formation and alveologenesis
To investigate Blimp1 functional requirements during ductal
morphogenesis, we used a Blimp1 conditional allele (Shapiro-
Shelef et al., 2003), in combination with the K14-Cre deleter strain,
termed here K14:Blimp1cKO. As expected, this strategy eliminates
Blimp1 expression in the skin and the entire mammary gland
epithelium (Fig. S2A). As judged by reduced numbers of TEBs and
ductal branches (Fig. 4A-C), Blimp1 mutant females display
defective ductal morphogenesis during puberty (5 and 6 weeks of
age). Mature virgin (10 weeks of age) mutant glands have
significantly fewer tertiary branches (Fig. 4I,J). We observed
impaired lumen formation (Fig. 4A-D,I), together with significantly
reduced numbers of bromodeoxyuridine (BrdU) and cleaved caspase-
3 positive (CC-3+) cells in the TEBs (Fig. 4E-H). Thus, loss of
Blimp1 disrupts proliferation of the TEB luminal cell compartment
and delays apoptosis-mediated clearing of intraluminal cells.
Fig. 2. Blimp1 expression marks highly
clonogenic luminal progenitors.
(A) Cryosections from 10-week-old virgin
BV mammary glands stained for GFP and
Elf5, ERα or PR. Blimp1-expressing cells
(green) are Elf5+ and ERα−/PR−.
(B) FACS-sorted BV+ luminal cells isolated
from 12-week-old virgin BV mice were
analysed by qRT-PCR for Elf5, Esr1 and
Pgr expression. The values were
normalized to Hprt expression. Data are
presented as mean±s.e.m. from n=3
independent experiments.
(C) Cryosections from 5- and 10-week-old
virgin (TEBs and ductal structures) and
P6.5 (alveoli) BV mice stained for GFP
(green) and Ki67 (red). High-magnification
images of the boxed areas in A,C are
shown below each image. (D) Histogram
showing the percentages of Ki67+BV−
(red), Ki67+BV+ (yellow) and Ki67−BV+
(green) at 5 and 10 weeks of age and at
P6.5. BV+ cells are highly proliferative in
5-week TEBs and P6.5 alveoli, but display
reduced proliferation in 10-week ducts.
Data are presented as mean±s.e.m.
from n=3 independent experiments.
(E) Representative images of colonies
formed by BV+ luminal cells isolated from
12-week-old virgin mice (n=3 independent
experiments). (F) Colony-forming
efficiency of BV+, BV− and unsorted
luminal cells (total) from 12-week-old virgin
and P18.5 mice. BV+ luminal cells form
significantly higher numbers of colonies
compared with BV− and unsorted luminal
cells. Data are presented as mean±s.e.m.
from n=3 independent experiments.
***P<0.001. Scale bars: 50 μm.
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Next, we tested the ability of primary MECs isolated from P15.5-
P16.5 mammary glands to form acini in 3D cultures (Akhtar and
Streuli, 2013). Blimp1cKO MECs were generated from Prdm1CA/CA
females harbouring the ROSA26:CreERT2 allele (Vooijs et al.,
2001) and treated in vitro with 4-hydroxy-tamoxifen (4OHT) to
induce Cre activity and eliminate Blimp1 expression (Fig. 5A).
CC-3+ intraluminal cells were initially visible in wild-type cultures
at day 3 (Fig. 5B), and the proportion of CC-3+ cells increased over
time. By day 6, complete clearing of the central lumen resulted in
the formation of cellular spheres that display normal apicobasal
polarity (Fig. 5B,C). By contrast, highly disorganized Blimp1-
depleted acini displayed reduced numbers of Ki67+ cells and
intraluminal CC-3+ cells, and failed to acquire correct apicobasal
polarity (Fig. 5). At day 10, mutant acini contain a high proportion
of CC-3+ cells, but still lack a distinct lumen (Fig. 5B). These
in vitro results recapitulate the reduced proliferative potential and
apoptosis-mediated luminal clearing defects observed in vivo
(Fig. 4; Fig. S3A,B).
To examine Blimp1 functional requirements at later stages
during pregnancy and lactation, we crossed the conditional allele
with the WAPi-Cre deleter strain (Fig. S4). The WAPi-Cre
transgene, initially expressed during pregnancy, is exclusively
localized to the luminal compartment (Wintermantel et al., 2002).
At P12.5, as for the K14:Blimp1cKO, in WAP:Blimp1cKO glands,
alveologenesis was severely compromised and numerous aberrant
TEB-like structures reminiscent of collapsed alveoli were
detectable (Fig. S4A,B). ErbB2 expression, required for normal
mammary development and lactation through activation of Nrg1
(Jones and Stern, 1999), was markedly reduced (Fig. S4C,D).
Additionally, the percentage of ERα+ cells was markedly elevated
(Fig. S4E,F). At late pregnancy, mutant glands display reduced
branching and small, sparsely distributed alveoli that were highly
vacuolated (Fig. S4G,H). Thus, we conclude that Blimp1 function
is required to promote lumen formation and lobuloalveolar
expansion.
Blimp1 inactivation causes epithelial cell polarity defects
during puberty, pregnancy and lactation
To investigate epithelial cell polarity defects during mammary
gland development, we examined localization of Par3 and the cis-
Golgi matrix protein 130 (GM130; also known as Golga2) (Fig. 6).
As expected, in control glands, Par3 localizes at tight junctions and
the apical surface of luminal cells. By contrast, in both mutant virgin
duct epithelia (Fig. 6A-C) and P18.5 alveoli (Fig. 6D-F), Par3
staining is more diffuse, and accumulates in the cytoplasm.
Similarly, in control epithelia, GM130 was predominantly
localized in an apical position facing the lumen. However, in
striking contrast, in Blimp1-deficient luminal cells GM130 was
dispersed within the cytoplasm and lacked its characteristic
polarized distribution.
Blimp1 inactivation in 3D MEC cultures via 4OHT treatment
similarly resulted in loss of luminal cell polarity. Thus, Par3 and
podocalyxin (Podx1) failed to accumulate at the apical surface
(Fig. 7A-D). Next, we used transmission electron microscopy
(TEM) to characterize the ultrastructural defects in Blimp1cKO day 6
3D acini (Fig. 7E). As expected, wild-type MECs display an apical
localization of the Golgi apparatus, and differentiated tight junctions
and microvilli, consistent with their mature apical surface. In
striking contrast, Blimp1cKO cells failed to develop tight junctions
or microvilli, and instead contained high numbers of large
endosome-, lysosome- and autophagosome-like structures.
Moreover, the Golgi apparatus was fragmented throughout the
cytosol of Blimp1cKO MECs. Thus, Blimp1 is essential to maintain
the alveolar secretory machinery.
Fig. 3. Expansion of Blimp1+ luminal cells in
response to hormone treatment. (A) Wild-type
and Prdm1Cre.IRES.nLacZ 10-week-old virgin mice
were ovariectomized, allowed to recover for
10 days (d) and injected over 6 days with a
cocktail of 17β-oestradiol and progesterone
(E2+Pg) or mineral oil as a control. Mammary
glands were recovered for analysis 7 days later.
(B) Whole-mount Carmine staining and Blimp1
immunostaining reveal mammary gland
expansion and enhanced Blimp1 expression in
response to E2+Pg treatment. Arrowheads
indicate the formation of alveolar buds (images
representative from two independent
experiments; n=5 mice per treatment). (C) X-gal-
stained whole-mount and tissue sections of
control (oil) or E2+Pg-treated Prdm1Cre.IRES.nLacZ
mammary glands. Sections were counterstained
with Nuclear Fast Red. Arrows indicate increased
numbers of Blimp1-lacZ+ cells in the alveolar
buds (images representative from two
independent experiments; n=5 mice per
treatment). Insets in B,C show high-magnification
images of the boxed areas. (D) RANKL treatment
results in significantly increased numbers of
Blimp1-lacZ+ cells. Day 6 3D MECs from
Prdm1Cre.IRES.nLacZ P15.5-P16.5 females were
treatedwith RANKL (24 h or 48 h) prior to staining.
(E) Percentage of Blimp1-lacZ+ acini in control
versus RANKL-treated cultures (control: n=30
acini; RANKL 24 h: n=30 acini; RANKL 48 h:
n=30). Error bars represent s.e.m. ***P<0.001.
Scale bars: 50 μm.
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Consistent with these defects, immunostaining experiments
together with qRT-PCR analysis revealed that expression of the
milk components Wap and β-casein was significantly reduced
(Fig. 8A-C). Stat5 phosphorylation in response to prolactin
signalling promotes alveolar cell differentiation and induction of
the milk protein gene signature (Liu et al., 1996). Nuclear
phospho-Stat5 (pStat5) bound directly to milk gene promoters
activates their expression (Jahchan et al., 2012). We found that
Blimp1-deficient mammary glands display significantly reduced
numbers of pStat5+ cells. However, Elf5 expression remains
unaffected (Fig. 8A,B,D). Moreover, neonatal pups nursed by
WAP:Blimp1cKO females have less milk in their stomachs, and
from birth onwards were growth retarded (Fig. 8E,F). Thus,
Blimp1 is required for alveolar secretory function during
pregnancy and lactation.
DISCUSSION
Mammary gland development and tissue homeostasis depends on
the combined activities of several distinct stem cell and progenitor
populations (Visvader and Stingl, 2014). Here, we identify the zinc
finger transcriptional repressor Blimp1 as a marker of a rare subset
of luminal progenitors, initially present during puberty, that
dramatically expand in response to pregnancy hormones giving
rise to alveolar cells. Additionally, conditional inactivation
experiments demonstrate that Blimp1 functional activity is
required to promote ductal morphogenesis during puberty, and
Fig. 4. Blimp1 conditional
inactivation results in defective
mammary gland morphogenesis.
(A,B) Whole-mount Carmine-stained
and histological sections of mammary
glands from 5- and 6-week-old virgin
K14:Blimp1cKO or littermate controls
(representative images from n=3mice
of each genotype). Red arrows
indicate TEBs. Black arrowheads
indicate defective lumen formation
within the TEBs. (C,D) Histograms
showing the number of TEBs (C), and
the percentage of the fat pad filled by
the invading mammary epithelial front
(D) past the mid-point of the lymph
node, assessed by whole-mount
staining. Histograms are presented as
mean±s.e.m. from n=3 mice of each
genotype. *P<0.05; **P<0.01.
(E,F) Decreased proliferation and
apoptosis. TEBs from 5- and 6-week-
old Blimp1-deficient virgins stained
for BrdU (green) and Krt8 (K8; red), or
cleaved caspase-3 (CC-3) show
markedly reduced numbers of BrdU+
and CC-3+ cells (arrows)
(representative images from n=3mice
of each genotype). (G,H) Significantly
reduced percentages of BrdU+ (G)
and CC-3+ (H) cells within TEBs from
5- and 6-week-old virgin Blimp1
mutants. Histograms are presented
as mean±s.e.m. from n=3 mice of
each genotype. (I) Whole-mount
Carmine-stained and histological
sections of mammary glands from
10-week-old virgin K14:Blimp1cKO or
littermate controls (representative
images from n=3 mice of each
genotype). Arrow indicates defective
lumen formation within ducts.
(J) Histograms showing the number of
primary, secondary and tertiary
branches within 10-week-old
mammary glands from K14:
Blimp1cKO and control littermates.
*P<0.05; **P<0.01. LN, lymph node.
Scale bars: 1 mm (whole mount);
50 μm (sections).
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drive terminal differentiation of the milk-secreting alveoli during
pregnancy.
It is well known that the luminal compartment comprises at least
two distinct cell subsets. The mature ERα+ cell population seems to
be mostly quiescent, with only rare proliferating cells detectable in
the adult mammary gland (Russo et al., 1999; Shehata et al., 2012).
Nonetheless, this population is essential for ductal morphogenesis
(Bocchinfuso et al., 2000; Feng et al., 2007; Mallepell et al., 2006;
Bernardo et al., 2010). Elf5 is widely viewed as an alveolar lineage-
specific master regulator because Elf5 mutant mammary glands
completely fail to initiate alveologenesis (Choi et al., 2009). The
ERα− luminal subpopulation, characterized by robust expression of
the Ets transcription factor Elf5 (Oakes et al., 2008; Rios et al.,
2014; Rodilla et al., 2015), is highly responsive to progesterone,
which acts indirectly via RANKL signalling to upregulate Elf5
expression and promote alveolar cell expansion and functional
maturation during pregnancy (Lee et al., 2013).
Here, we identify a novel subset of Blimp1+ERα−Elf5+ luminal
progenitors. This rare but highly clonogenic subpopulation initially
appears within the expanding ductal tree during puberty. However,
at the onset of pregnancy this population expands dramatically. As
for Elf5+ progenitors, Blimp1+ cells, representing <0.5% of the
luminal population in virgin or pregnant females (Rios et al., 2014),
possess a markedly elevated clonogenic capacity. Strikingly, in
virgins 40% of isolated Blimp1+ luminal cells possess high self-
renewal capacity and give rise to discrete colonies. At P18.5, >80%
have clonogenic potential, compared with <10% for the Blimp1−
luminal cells. Blimp1 expression marks a unique population of
progenitors that can contribute to both ductal and alveolar
structures. The number of Blimp1+ progenitors within the
epithelium dramatically increases in response to progesterone and
oestrogen hormone treatment. Similarly, MEC cultures upregulate
Blimp1 expression in response to RANKL stimulation. Thus, as for
Elf5, Blimp1 is probably activated downstream of paracrine
RANKL signalling from the adjacent ERα+PR+ luminal
subpopulation. Interestingly, this RANKL-Nfatc1 signalling axis
similarly induces Blimp1 expression during osteoclast
differentiation (Nishikawa et al., 2010). Future work exploiting
inducible labelling strategies will be necessary to define further the
dynamic functional contribution made by this Blimp1+ cell lineage
during successive rounds of pregnancy and lactation.
The present conditional inactivation experiments demonstrate
Blimp1 functions at early stages during puberty to promote TEB
remodelling (Mailleux et al., 2007).Blimp1mutant epitheliumdisplays
pronounced defects in lumen formation and ductal morphogenesis,
associated with decreased proliferation and apoptosis. However,
expansion of the ductal tree and induction of the alveolar buds
during pregnancy proceeds normally. Rather, Blimp1 loss disrupts
clearing of intraluminal and terminal differentiation of the alveoli
responsible for milk production (Jahchan et al., 2012).
Fig. 5. Loss of Blimp1 delays lumen formation in MEC 3D cultures. (A) Immunostaining of day 3 wild-type and Prdm1BEH/CA;ROSA26:CreERT2 (Blimp1cKO)
MEC 3D acini for Blimp1. Treatment with 100 nM 4OHT (to induce Cre) results in elimination of Blimp1 in Blimp1cKO acini (representative images from n=3
independent experiments). (B) Immunostaining at day 3, 4, 5, 6 and 10 of wild-type and Blimp1cKO MEC 3D acini for CC-3+ (red) and actin (green) (representative
images from three independent experiments). Loss of Blimp1 results in altered apoptosis-mediated clearing of intraluminal cells. (C) Percentage of CC-3+ luminal
cells. Data are presented as mean±s.e.m. values from day 3 (wild type: n=30 acini; Blimp1cKO: n=31 acini); day 4 (wild type: n=33 acini; Blimp1cKO: n=30 acini);
and day 5 (wild type: n=32 acini; Blimp1cKO: n=32 acini) 3D cultures. (D) Percentage of Ki67+ luminal cells was significantly reduced in Blimp1cKO MECs at day 3
and 4 compared with wild type. Data are presented as mean±s.e.m. values from day 3 (wild type: n=30 acini; Blimp1cKO: n=30 acini) and day 4 (wild type: n=30
acini; Blimp1cKO: n=30 acini) 3D culture. Error bars represent s.e.m. ***P<0.001. Scale bars: 50 μm.
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The establishment of epithelial polarity is required for functional
maturation of alveolar cells (Choi et al., 2009; Elias et al., 2015;
Jahchan et al., 2012). The present experiments uncover a
requirement for Blimp1 in establishment of apical polarity. The
Golgi apparatus is highly disorganized in mutant mammary gland
tissue in both in vivo and in vitro Blimp1-depleted acini. Blimp1 is
required to establish initial polarity as well as subsequent
segregation of apical and basolateral compartments. Elf5 regulates
expression of the tight junction and cell-cell adhesion molecules
necessary during alveolar maturation (Choi et al., 2009).
Induction of milk synthesis by the alveolar cells occurs during
pregnancy in response to prolactin-mediated activation of Stat5
(Miyoshi et al., 2001). pStat5 activation downstream of the prolactin
receptor regulates expression of key milk protein components,
including β-casein and Wap (Liu et al., 1995; Schmitt-Ney et al.,
1991). Stat5 mutants display defective lobuloalveolar development
and lactation failure (Cui et al., 2004). Blimp1 conditional
inactivation results in dramatically reduced Stat5 activity and
impaired milk production. By contrast, loss of Blimp1 has no
noticeable effect on Elf5 expression, also upstream of Stat5
activation (Choi et al., 2009). Rather, in the absence of Blimp1
here we observe defective luminal proliferation and polarization
defects, suggesting that reduced Stat5 activation in Blimp1 mutant
cells reflects diminished receptor availability at the cell surface.
The present study identifies Blimp1 as a novel regulator of
alveologenesis acting upstream to orchestrate secretory activation.
In the B-cell lineage, Blimp1 functions as a master regulator
governing terminal differentiation, and Blimp1 is both necessary
and sufficient for maturation into immunoglobulin-secreting plasma
cells (Martins and Calame, 2008). Thus, enforced Blimp1
overexpression drives mature B cells to become professional
secretory cells. Similarly, here we have uncovered a key
requirement for Blimp1 for maturation of the highly specialized
milk-secreting cells of the mammary gland. It will be interesting to
learn more about potentially common regulatory mechanisms
governing Blimp1 functional roles in these professional secretory
cell lineages.
Intriguingly, Blimp1 loss of function is accompanied by ectopic
ERα expression in both the ductal and alveolar epithelium. Recent
studies of human breast cancer cell lines suggest that Blimp1
directly represses ERα mRNA expression (Wang et al., 2009).
However, this site was not identified in recent genome-wide
Blimp1 chromatin immunoprecipitation analysis (Mould et al.,
2015). Thus, the extent to which Blimp1 directly targets ERα
expression in vivo, and possibly contributes to governing the
balance of ERα+ versus ERα− cell populations during mammary
gland homeostasis and remodelling, remains unknown. Poorly
differentiated breast cancers are thought to arise from ERα− luminal
progenitors (Molyneux et al., 2010; Pratt et al., 2009). Here, we
identified Blimp1 as a novel marker for luminal ERα− progenitors.
Given the established link between Blimp1 and EMT in breast
cancer, unravelling the mechanisms that underlie Blimp1 functions
in mammary gland development should not only yield important
insights into stem cell/progenitor cell populations in the mammary
epithelium but also contribute to a better understanding of breast
cancer biology.
MATERIALS AND METHODS
Animals
C57BL/6 mice were used as the wild-type strain. The BAC transgenic
reporter strain expressing membrane-targeted Venus under the control of the
Blimp1 regulatory elements (Prdm1-mVenus; BV) has been described
(Ohinata et al., 2008). For tissue-specific deletion experiments, K14-Cre
(Vasioukhin et al., 1999) or WAPi-Cre (Wintermantel et al., 2002) animals
were intercrossed with Prdm1BEH/+ (Vincent et al., 2005) animals to
generate heterozygous K14-Cre,Prdm1BEH/+ or WAPi-Cre,Prdm1BEH/+
males that were then mated with homozygous Prdm1CA/CA females
(Shapiro-Shelef et al., 2003) to generate control (Prdm1CA/+, WAPi-Cre or
K14-Cre), heterozygous (K14-Cre,Prdm1CA/+; WAPi-Cre,Prdm1CA/+, or
Prdm1BEH/+) or null (WAPi-Cre;Prdm1CA/BEH or K14-Cre;Prdm1CA/BEH)
females (referred to as K14:Blimp1cKO and WAP:Blimp1cKO, respectively).
For Blimp1 gene deletion in mammary epithelial culture, Prdm1BEH/+ and
Prdm1CA/CAmicewere crossed with the ROSA26:CreERT2 line (Vooijs et al.,
2001) to generate Prdm1BEH/CA;ROSA26:CreERT2 females (referred to as
Blimp1cKO). Mice were genotyped by PCR as described in the original
Fig. 6. Blimp1 inactivation causes epithelial cell polarity defects during puberty, pregnancy and lactation. (A) Representative images of 10-week-old
mammary glands from K14:Blimp1cKO and control littermates stained for GM130 (green) and Par3 (red) (n=3 mice of each genotype). (B) Representative line-
scan analysis (relative fluorescence intensity; minimum of 20 cells were analysed per genotype), reveals a failure of Par3 apical accumulation in Blimp1-deficient
ductal cells. (C) Percentages of ductal cells showing ribbon-like and fragmented localization of GM130 Golgi in control and Blimp1-mutant mammary glands.
(D) Representative images of mammary glands (P18.5) from K14:Blimp1cKO, WAP:Blimp1cKO and control littermates stained for GM130 (green) and Par3 (red)
(n=3mice of each genotype). High-magnification images of the boxed areas in A,D are shown below. (E) Representative line-scan analysis (relative fluorescence
intensity; minimum of 20 cells were analysed per genotype), reveals lack of Par3 apical accumulation in Blimp1-deficient alveolar cells. (F) Percentages of alveolar
cells showing ribbon-like and fragmented localization of GM130 Golgi in control and Blimp1-mutant mammary glands. Scale bars: 50 μm.
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reports. All animal experiments were performed in accordance with Home
Office (UK) regulations and approved by the University of Oxford Local
Ethical Committee.
Ovariectomy and hormone treatment
Wild-type and Prdm1Cre.IRES.LacZ 8- to 10-week-old female mice were
bilaterally ovariectomized and allowed to recover for 10 days. Mice were
divided into two experimental groups (control and hormone treated), and
injected subcutaneously with 100 µl mineral oil alone or containing 10 µg
17β-oestradiol (E2) (Sigma) plus 1 mg progesterone (Pg) (Sigma) (E2+Pg)
as previously described (Joshi et al., 2010). Mammary tissues were stained
for Carmine and X-gal as described previously (Elias et al., 2014).
Whole mounts and quantification of ductal morphogenesis
For whole-mount Carmine staining, inguinal mammary glands were fixed
overnight with Carnoy’s solution (60%methanol, 30% chloroform and 10%
glacial acetic acid), hydrated in an ethanol series, stained with Carmine
Alum (1% Carmine, 2.5% aluminum; Sigma, UK), then dehydrated in
ethanol and cleared with Histo-clear II (National Diagnostics) as described
previously (Elias et al., 2014).
Mammary gland development was quantified as described elsewhere (Elias
et al., 2015). In brief, the degree of ductal invasion was determined by
dividing the duct length by the mammary gland length from the mid-point of
the lymph node, and the numbers of total branches and TEBswere determined
on whole-mount images using ImageJ (http://rsb.info.nih.gov/ij/; NIH, US).
Histological analysis and immunostaining
Mammary glands were dissected, fixed overnight in 4% paraformaldehyde
(PFA), embedded in paraffin, sectioned (6 μm) and stained with
Haematoxylin and Eosin (H&E) for histological analysis. For
immunostaining, paraffin sections (6 μm) were deparaffinized, rehydrated
and subjected to antigen retrieval by boiling for 1 h in either sodium citrate,
pH 6.0 (Wap, β-casein, ErbB2) or Tris-EDTA pH 9.0 [Krt8, Ki67, p63 (also
known as Trp63), cleaved caspase-3, oestrogen receptor α (ERα), Blimp1,
Par3, podocalyxin and GM130] (Table S1). Sections were incubated
overnight at 4°C in primary antibodies, washed in PBS, developed using
the appropriate Envision peroxidase-labelled polymer kit (Dako) and
counterstained with Haematoxylin. For double immunofluorescence,
paraffin sections were antigen retrieved as described above followed by
application of primary antibodies (Table S1). Alternatively, PFA-fixed
frozen sections (30-50 µm) were cut, air-dried for 30 min, permeabilized for
45 min in PBS/0.2% Triton X-100, and incubated for 2 h in BSA/FBS block
[2% bovine serum albumin (BSA), 5% fetal bovine serum (FBS), 0.2%
Triton X-100 in PBS]. Sections were incubated overnight at 4°C with
primary antibodies, followed by incubation for 1 h at room temperature with
secondary antibodies. Secondary antibodies were conjugated to Alexa Fluor
488 or Alexa Fluor 594 (Life Technologies). Sections were counterstained
with DAPI-containing Fluoroshield (Sigma). Immunofluorescence images
were captured with an inverted Olympus FV1000 laser scanning confocal
microscope equipped with ×40 and ×60 oil-immersion objectives. z-stacks
were collected at 1-μm intervals. Images were analysed with ImageJ. A full
description of antibodies is provided in the Table S1.
BrdU pulse-chase experiments and apoptotic cell analysis in
TEBs
To assess cell proliferation, 0.25 mg 5-bromo-2-deoxyuridine (BrdU,
Sigma) per gram of body weight was injected intraperitoneally 2 h prior
to sacrifice. Mammary glands fixed in 4% PFA were paraffin embedded,
Fig. 7. Loss of Blimp1 alters lumen formation and maturation in MEC 3D cultures. (A) Wild-type and Prdm1CA/CA:ROSA26:CreERT2 (Blimp1cKO) day 6
4OHT-treated MEC 3D acini stained for GM130 (green) and Par3 (red; top panel) or podocalyxin (Podxl, red; bottom panel). MECs were treated with 4OHT for
24 h following plating. Scale bars: 50 μm. (B) Percentage of acini with ribbon-like and fragmented localization of GM130 Golgi in wild-type and Blimp1cKO day 6
4OHT-treatedMEC 3D acini (wild type: n=30 acini; Blimp1cKO: n=30 acini). (C) Deviation of the Golgi from acini centre (α°) (wild type: n=30 acini; Blimp1cKO: n=30
acini). (D) Percentage of acini with Golgi uncoupled to centre (wild type: n=30 acini; Blimp1cKO: n=30 acini). Data are presented as mean±s.e.m. ***P<0.001.
(E) Representative electron micrographs of wild-type and Blimp1cKO day 6 4OHT-treated MEC 3D acini revealing alterations in the establishment of an apical-
basal polarity in mutant acini compared with wild type, accompanied by dismantled tight junctions (1′ vs 1; arrowheads), fragmentation of the Golgi apparatus
(2′ vs 2; arrows) and loss of apical villi.
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sectioned (6 μm) and stained using anti-Krt8 and BrdU antibodies. The
numbers of BrdU+ cells were counted as a percentage of total number of
cells within each TEB of 5- and 6-week-old virgin mice. A minimum of ten
TEBs from three separate mice (∼2-3×103 cells) were counted per genotype.
To assess cell death, paraffin sections were assessed for CC-3. The
percentage of immunoreactive cells within TEBs was determined from a
minimum of ten TEBs, from three separate mice (∼104 cells) per genotype,
as described previously (Wiseman et al., 2003).
X-gal staining
Mammary glands were fixed in 1% PFA overnight at 4°C, washed in PBS
and stained overnight at 37°C in X-gal staining solution [0.5 mg/ml X-gal,
5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 5 mM ethylene glycol tetra-acetic
acid (EGTA), 2 mM MgCl2, 10% NP-40, 0.01% deoxycholic acid]. Tissue
was then dehydrated, embedded in paraffin, sectioned (6 μm) and
counterstained with Nuclear Fast Red.
Isolation of mammary epithelial cells and flow cytometry
Mammary epithelial cells (MECs) and the separation of basal and luminal
cells were performed as described elsewhere (Stingl et al., 2006; Taddei
et al., 2008). Once mechanically dissociated, mammary fat pads were
digested (90 min, 37°C) in CO2-independent medium (Invitrogen)
containing 5% FBS, 3 mg/ml collagenase A (Roche Diagnostics) and
100 U/ml hyaluronidase (Sigma). Cells were resuspended in 0.25% trypsin-
EDTA (1 min), and then in 5 mg/ml dispase (Roche Diagnostics) with
0.1 mg/ml DNase I (Sigma) (5 min). Red blood cells were lysed with
0.17 mM NH4Cl. Basal and luminal cells were isolated from mammary
epithelial cells obtained from the inguinal glands. Cells were stained with
the following antibodies: CD24-PerCP-Cy5.5 (clone M1/69; BD
Pharmingen), CD49f-PE (clone GoH3; BD Pharmingen), CD45-APC
(clone 30-F11; Biolegend) and CD31-APC (clone MEC13.3; Biolegend).
Basal (CD24-low/CD49f-high) and luminal (CD24-high/CD49f-low) cells
were purified using MoFlo XDP Flow Cytometer (Beckman Coulter).
Mammary colony-forming assays
In vitro Matrigel colony-forming assays were performed as described
(Stingl et al., 2006). Single mammary cell suspensions were prepared from
the inguinal glands and 3000 unsorted cells or sorted luminal cells were
seeded in 50 µl Matrigel and cultured in DMEM/F12 medium containing
1% FBS (HyClone Laboratories) and B27 (Life Technologies). Colonies
were scored after 6 days.
Primary cell 3D culture, gene deletion, immunofluorescence and
transmission electron microscopy (TEM)
Primary MECs were collected from 15.5- and 16.5-day pregnant mice and
cultured as described (Akhtar and Streuli, 2013). Cells were seeded onto
Matrigel (BD Biosciences) to form acini and cultured in growth
media [DMEM/F12 medium (Life Technologies) containing 5 µg/ml
insulin, 1 µg/ml hydrocortisone (Sigma), 3 ng/ml epidermal growth factor
(EGF), 10% FBS, 50 U/ml penicillin/streptomycin, 0.25 µg/ml fungizone
and 50 µg/ml gentamycin]. Cells (2×104) were plated in each well of 8-well
LabTek II chamber slides (Thermo Fisher Scientific) pre-coated with
Matrigel (25 μl per well). Cells were fed every 48 h and grown for 3-
10 days. Cre-mediated deletion of Blimp1 in primary MEC cultures was
Fig. 8. Blimp1 function is essential for alveolar
maturation during pregnancy and lactation.
(A,B) Representative images of mammary glands
(P18.5) stained for pStat5, p63 (green), Wap (red) or
β-casein (red), and Elf5 (representative images from
n=3 mice of each genotype); black arrows indicate a
dramatic reduction of pStat5+ cells and white arrows
indicate markedly reduced expression of milk
proteins Wap and β-casein in mutant alveoli.
Asterisks indicate areas showing normal expression
levels of Wap. The numbers of p63+ basal cells are
similar in control and mutant tissues. (C) qRT-PCR
analysis demonstrates markedly reduced expression
of Csn2 (β-casein) and Wap transcripts in total
mammary gland mRNA samples from Blimp1
mutants. The values were normalized to Krt8
expression. Data are presented as mean values from
n=2 mice of each genotype. (D) Quantification of
pStat5+ cells from Blimp1 mutants and littermate
controls. Data are presented as mean±s.e.m. values
from n=3 mice of each genotype. ***P<0.001.
(E) Pups nursed by lactating WAP:Blimp1cKO mutant
females display growth retardation. Pups were
weighed daily for 10 days. Body weights of pups are
shown as mean±s.e.m. per litter per day, n=2
lactating females nursing identical litter sizes
(P=0.0002). A total of 15 pups for each genotype
were analysed. (F) Representative photographs of
day 5 pups nursed by control and WAP:Blimp1cKO
females. Scale bars: 50 μm.
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achieved by collecting MECs from wild-type or Prdm1BEH/CA;ROSA26:
CreERT2mice and treating with 100 nM 4OHT (Sigma) dissolved in ethanol
for 24 h.
MEC cultures derived from Prdm1Cre.IRES.LacZ mice were incubated with
or without 200 ng/ml murine RANKL (PeproTech) for 24 or 48 h, followed
by X-gal staining as described above.
Acini were fixed with 4% PFA and permeabilized with 0.5% Triton X-100
in PBS. Fixed cells were blocked with 10% normal goat serum/2% BSA in
PBS for 2 h, and then incubatedwithBlimp1, F-actin, cleaved caspase-3, Par3,
GM130 and Ki67 antibodies (Table S1) overnight at 4°C. Cells were stained
with mouse and rabbit Alexa Fluor 488- or Alexa Fluor 555-conjugated
antibodies.AciniwithF-actin staining at the apical surfaceof cells surrounding
a single lumen were identified as acini with normal lumens. For all
immunostaining, slides were mounted in DAPI-containing Fluoroshield.
The pictures were captured with an inverted Olympus FV1000 laser scanning
confocal microscope equipped with ×40 and ×60 oil-immersion objectives. z-
stack steps were of 1 μm. Images were analysed with ImageJ.
For TEM analysis, day 6 acini were first fixed with 4% PFA plus 2.5%
glutaraldehyde in 0.1 M PIPES buffer (pH 7.2; Sigma) for 2 h at room
temperature, and then overnight at 4°C. Samples were washed with
0.1 M PIPES buffer and incubated in 1% osmium tetroxide (OsO4;
TAAB Laboratories) in 0.1 M PIPES buffer at 4°C for 2 h with gentle
rotation. The samples were washed with water, then en bloc stained with
0.5% aqueous uranyl acetate (TAAB Laboratories) overnight at 4°C in
the dark. The samples were gradually dehydrated in ethanol at 4°C
(15 min each with 30%, 70% 50%, 80%, 90%, 95%, 100% ethanol),
infiltrated with TAAB TLV resin over 3 days, then polymerized
overnight at 60°C. Ultrathin (90 nm) sections were taken using a
Diatome diamond knife on a Leica Ultracut7 ultramicrotome. Sections
were post-stained with lead citrate for 5 min, then examined on a Tecnai
12 transmission electron microscope (FEI) equipped with a Gatan
OneView CMOS camera.
Quantification and image analyses
Tomeasure relative fluorescence intensity at the apical surface, a 30-pixel line
was drawn across the apical surface and the cytoplasm using ImageJ software.
The line scan function of ImageJ was used to reveal the relative fluorescence
intensity across the line. TomeasureGolgi orientation in 3D culture, we used a
macro developed for ImageJ as described previously (Elias et al., 2015).
RNA extraction and qRT-PCR
Total RNAwas extracted from MECs obtained by FACS sorting, 3D MEC
cultures or from digested whole-mount mammary glands using the RNeasy
Mini Kit (Qiagen). RNA (1 μg) was used to synthesize first-strand cDNA
(Invitrogen) followed by real-time PCR using QuantiTech SYBR Green
master mix (Q2040143; Qiagen) on a Rotor-Gene Q (Qiagen). Primer
sequences are provided in Table S2.
Statistical analyses
GraphPad Prism 6.0 software was used for statistical analysis. Data are
shown as mean±standard error of the mean (s.e.m.). Student’s t-test was
used where applicable, with P<0.05 considered significant. Comparison of
body weights of pups suckled by Blimp1 mutant or wild-type females was
analysed by two-way ANOVA with repeated measures.
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SUPPLEMENTARY FIGURES 
Fig. S1. Characterization of Blimp1-expressing cells using flow cytometry. (A) Gating 
cascade: samples were gated on forward and side scatter (FSC/SSC) to exclude debris, and 
single cells were isolated using time-of-flight analysis on both FSC and SSC. CD45+ 
leukocytes and CD31+ endothelial cells were removed and total epithelial cells gated on a 
CD24/CD49f   plot. Epithelial subpopulations were isolated from the total epithelial cell  D
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Development 143: doi:10.1242/dev.136358: Supplementary information
population. (B) qRT-PCR analysis of Krt14 and Krt18 expression in basal (CD31-/CD45- /
CD24+/CD49fhigh) and luminal (CD31-/CD45-/CD24+/CD49flow) cell populations isolated 
from 12-week virgin control mammary glands. Data are presented as mean ± s.e.m values 
from n=2 independent experiments. (C) qRT-PCR analysis of Blimp1 mRNA in basal versus 
luminal mammary epithelial cells isolated from 12-week virgins and P18.5 mice. qRT-PCR 
values were normalized to Hprt expression. Data are presented as mean ± s.e.m values from 
n=2 independent experiments, and confirm that Blimp1 is restricted to luminal cells. (D) 
Histograms showing the percentages of BV+ luminal cell relative to gated total or luminal 
cells isolated from 12-week virgin or P18.5 mammary glands. Data are presented as mean ± 
s.e.m values from n=2 independent experiments. Error bars, s.e.m. ** p < 0.01. (E) 
Representative dot plots showing an enrichment of BV+ cells within the luminal population 
from 12-week virgin and P18.5 mammary glands. 
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Fig. S2. Efficacy of Cre-mediated of Blimp1 deletion from mammary gland epithelia. (A 
and B) Immunostaining of mammary glands (P18.5) and epidermis from K14:Blimp1cKO and 
WAP:Blimp1cKO and littermate control mice (representative of n=3 mice of each genotype). 
Blimp1 protein was not detected in mammary epithelia of either K14:Blimp1cKO or 
WAP:Blimp1cKO tissue. Images representative of n=3 mice of each genotype. Arrowheads 
indicate Blimp1+ cells in the hair follicle (sebocytes) and in the granular layer of the 
epidermis. Scale bars, 50µm.  
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Fig. S3. Loss of Blimp1 alters lumen formation during pregnancy. (A and B) 
Immunostaining of Blimp1 mutant mammary glands and littermate controls for CC-3 and 
KI67 at P12.5 and P18.5 (representative images from n=3 mice of each genotype). 
Immunostaining shows a reduction in the number of CC-3+ cells (arrow) at P12.5 mutant 
mammary glands. Data are presented as mean ± s.e.m values from n=3 mice of each 
genotype. Error bars represent s.e.m values. * p <0.05. CC-3+ cells (arrow) were detected in 
mutant mammary epithelia at P18.5, while markedly reduced levels of KI67+ cells (arrow) 
were observed in mutant alveoli (representative images from n=3 mice of each genotype). All 
scale bars, 50µm.  
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Figure S4. Loss of Blimp1 severely impacts lobuloalveolar development. (A and B) 
Histological sections of mammary glands at P12.5 from K14:Blimp1cKO, WAP:Blimp1cKO 
and littermate control mice. Arrowheads indicate collapsed alveoli in mutant mammary  D
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epithelia (representative images from n=3 mice of each genotype). (C and D) 
Immunofluorescence staining for K8 (red) and ErbB2 (green). (E) Increased number of ERα+ 
cells observed in 10-week-old mutant mammary epithelia (images representative of n=3 mice 
of each genotype). (F) Histograms showing the percentages of ERα+ at 10 weeks of age in 
control and mutant mammary epithelia's. Data are presented as mean ± s.e.m values from n=3 
independent experiments. (G and H) Whole mount carmine staining and histological sections 
from P18.5 K14:Blimp1cKO, WAP:Blimp1cKO and control littermate mammary glands 
(representative images from n=3 mice of each genotype). Arrows indicate disorganized and 
vacuolated alveoli in Blimp1 mutant mammary glands. ** p < 0.01. All scale bars, 50 µm.  
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Table	  S1:	  List	  of	  Antibodies	  
Antibody Supplier Cat No Host Species Dilution Application 
anti-Cleaved-Caspase-3 Cell Signaling 9664 Rabbit polyclonal 1 in 100 IHC 
anti-β-casein Santa Cruz Biotechnology sc-30042 Rabbit polyclonal 1 in 100 IF 
anti-Blimp-1 Santa Cruz Biotechnology sc-130917 Rat monoclonal 1 in 500 IHC/IF/ICC 
anti-BrdU Becton Dickinson 347580 mouse monoclonal 1 in 100 IF 
anti-CD24-PerCP-Cy5.5 clone M1/69 BD Pharmingen 562360 Rat monoclonal 1 in 200 FACS 
anti-CD31-APC clone MEC13.3 BD Pharmingen 551262 Rat monoclonal 1 in 200 FACS 
anti-CD45-APC clone 30-F11 BD Pharmingen 559864 Rat monoclonal 1 in 200 FACS 
anti-CD49f-PE clone GoH3 BD Pharmingen 561894 Rat monoclonal 1 in 50 FACS 
anti-Elf5 Santa Cruz Biotechnology sc-9645 Goat polyclonal 1 in 100 IF 
anti-ErbB2 Abcam ab2428 Rabbit polyclonal 1 in 100 IF 
anti-ERα Santa Cruz Biotechnology sc-542 Rabbit polyclonal 1 in 200 IHC/IF 
anti-GFP-A488-conjugate Invitrogen/MP A-31851 Rabbit polyclonal 1 in 400 IF 
anti-GFP Abcam Ab13970 chicken polyclonal 1 in 1000 IF 
anti-Keratin 14 Cambridge Bioscience PRB-
155P 
Rabbit Polyclonal 1 in 2000 IF 
anti-Keratins 8 Progen Biotechnik GP11 Guinea-Pig polyclonal 1 in 50 IF 
anti-Ki67 Abcam ab15580 Rabbit polyclonal 1 in 100 IF 
anti-p63 Abcam ab735 Mouse monoclonal 1 in 40 IF 
Phalloidin-Alexa Fluor 633 Invitrogen/MP A22284 1 in 100 IF/ICC 
anti-pStat5 (Tyr694) Cell Signaling 9314 Rabbit polyclonal 1 in 100 IHC 
anti-WAP Santa Cruz Biotechnology sc-25526 Rabbit polyclonal 1 in 100 IF 
GM130 BD Pharmingen 610822 Mouse monoclonal 1 in 200 IF 
Par3 Millipore 07-330 Rabbit polyclonal 1 in 200 IF 
Podocalyxin R&D systems MAB1556 Rat polyclonal 1 in 200 IF 
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Gene Protein Epithelial 
compartment 
Primer sequence 
Prdm1 Blimp1 
Luminal Forward: GGCTCCACTACCCTTATCCTG;  
Reverse:  TCCTTTTGGAGGGATTGGAGTC 
Venus Yellow fluorescent protein (YFP) 
Forward: CGACTCTAGATCATAATCAGCC;  
Reverse: TAAGATACATTGATGAGTTTGGAC 
Elf5 E74-like factor 5 (ELF5), luminal progenitors 
Forward: CCAACGCATCCTTCTGTGAC; 
Reverse: AGGCAGGGTAGTAGTCTTCA 
Esr1 Estrogen receptor 1 (ER1), mature luminal cells 
Forward: CTGGACAGGAATCAAGGTAAA; 
Reverse: GAGGCACACAAACTCTTCTC 
WAP Whey acidic protein (Milk protein) 
Forward: AACATTGGTGTTCCGAAAGC; 
Reverse: GGTCGCTGGAGCATTCTATC 
Csn2 Beta casein (Milk protein) 
Forward: TGCAGGCAGAGGATGTGCTCCAGGC; 
Reverse: GGCCTGGGGCTGTGACTGGATGCT 
Krt8/18 Cytokerain 8/18 
Forward: CGAGGCACTCAAGGAAGAAC-; 
Reverse: AATCTGGGCTTCCAGACCTT 
Pgr Progestrone Receptor 
Forward: CCACCTGTACTGCTTGAATAC, 
Reverse: CAACTGGGCAGCAATAACTTC 
Krt14 Cytokerain 14 Basal 
Forward: GCTCTTGTGGTATCGGTGGT;  
Reverse: GAGGAGAAGCGAGAGGAGGT 
Hprt 
Hypoxanthine-guanine phosphoribosyltransferase 
(Hprt)  
Forward: GCTGGTGAAAAGGACCTCT;  
Reverse: CACAGGACTAGAACACCTGC 
Table S2: List of Primers 
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